Pharma-Bio Serv Ownership
| PBSV Stock | USD 0.55 0.12 27.91% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Pharma-Bio |
Pharma-Bio OTC Stock Ownership Analysis
About 65.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.15. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Pharma Bio Serv last dividend was issued on the 24th of February 2022. Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico. Pharma Bio operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 190 people.The quote for Pharma Bio Serv is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To find out more about Pharma Bio Serv contact Victor Sanchez at 787 278 2709 or learn more at https://www.pharmabioserv.com.Pharma-Bio Serv Outstanding Bonds
Pharma-Bio Serv issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Pharma Bio Serv uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Pharma-Bio bonds can be classified according to their maturity, which is the date when Pharma Bio Serv has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| PHARMACIA P 66 Corp BondUS71713UAW27 | View | |
| PHARMACIA P 675 Corp BondUS71713UAT97 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Pharma-Bio OTC Stock Analysis
When running Pharma-Bio Serv's price analysis, check to measure Pharma-Bio Serv's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharma-Bio Serv is operating at the current time. Most of Pharma-Bio Serv's value examination focuses on studying past and present price action to predict the probability of Pharma-Bio Serv's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharma-Bio Serv's price. Additionally, you may evaluate how the addition of Pharma-Bio Serv to your portfolios can decrease your overall portfolio volatility.